EyePoint Pharmaceuticals Inc (EYPT)
8.345
-0.61
(-6.81%)
USD |
NASDAQ |
Nov 21, 16:00
8.345
0.00 (0.00%)
After-Hours: 20:00
EyePoint Pharmaceuticals Price to Book Value: 2.604 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.794 |
| November 19, 2024 | 2.874 |
| November 18, 2024 | 2.677 |
| November 15, 2024 | 2.861 |
| November 14, 2024 | 3.273 |
| November 13, 2024 | 3.357 |
| November 12, 2024 | 3.467 |
| November 11, 2024 | 3.744 |
| November 08, 2024 | 3.629 |
| November 07, 2024 | 3.616 |
| November 06, 2024 | 3.769 |
| November 05, 2024 | 3.623 |
| November 04, 2024 | 3.651 |
| November 01, 2024 | 3.763 |
| October 31, 2024 | 3.669 |
| October 30, 2024 | 2.804 |
| October 29, 2024 | 2.824 |
| October 28, 2024 | 2.966 |
| October 25, 2024 | 2.325 |
| October 24, 2024 | 2.339 |
| October 23, 2024 | 2.437 |
| October 22, 2024 | 2.630 |
| October 21, 2024 | 2.618 |
| October 18, 2024 | 2.704 |
| October 17, 2024 | 2.728 |
| Date | Value |
|---|---|
| October 16, 2024 | 2.760 |
| October 15, 2024 | 2.418 |
| October 14, 2024 | 2.489 |
| October 11, 2024 | 2.161 |
| October 10, 2024 | 2.016 |
| October 09, 2024 | 2.053 |
| October 08, 2024 | 2.075 |
| October 07, 2024 | 2.131 |
| October 04, 2024 | 2.112 |
| October 03, 2024 | 2.048 |
| October 02, 2024 | 2.009 |
| October 01, 2024 | 1.958 |
| September 30, 2024 | 1.955 |
| September 27, 2024 | 1.871 |
| September 26, 2024 | 1.892 |
| September 25, 2024 | 1.910 |
| September 24, 2024 | 1.955 |
| September 23, 2024 | 1.943 |
| September 20, 2024 | 2.089 |
| September 19, 2024 | 2.152 |
| September 18, 2024 | 2.089 |
| September 17, 2024 | 2.058 |
| September 16, 2024 | 2.072 |
| September 13, 2024 | 2.133 |
| September 12, 2024 | 2.082 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5924
Minimum
Dec 19 2022
26.93
Maximum
Jan 28 2020
5.989
Average
3.253
Median
Price to Book Value Benchmarks
| Cassava Sciences Inc | 9.294 |
| Regeneron Pharmaceuticals Inc | 2.790 |
| Adverum Biotechnologies Inc | 0.8329 |
| Regenxbio Inc | 1.514 |
| Editas Medicine Inc | 1.116 |
Price to Book Value Related Metrics
| PS Ratio | 9.254 |
| Price | 8.345 |
| Earnings Yield | -23.85% |
| Market Cap | 569.55M |